Your browser doesn't support javascript.
loading
Evolutionary characterization of lung adenocarcinoma morphology in TRACERx.
Karasaki, Takahiro; Moore, David A; Veeriah, Selvaraju; Naceur-Lombardelli, Cristina; Toncheva, Antonia; Magno, Neil; Ward, Sophia; Bakir, Maise Al; Watkins, Thomas B K; Grigoriadis, Kristiana; Huebner, Ariana; Hill, Mark S; Frankell, Alexander M; Abbosh, Christopher; Puttick, Clare; Zhai, Haoran; Gimeno-Valiente, Francisco; Saghafinia, Sadegh; Kanu, Nnennaya; Dietzen, Michelle; Pich, Oriol; Lim, Emilia L; Martínez-Ruiz, Carlos; Black, James R M; Biswas, Dhruva; Campbell, Brittany B; Lee, Claudia; Colliver, Emma; Enfield, Katey S S; Hessey, Sonya; Hiley, Crispin T; Zaccaria, Simone; Litchfield, Kevin; Birkbak, Nicolai J; Cadieux, Elizabeth Larose; Demeulemeester, Jonas; Van Loo, Peter; Adusumilli, Prasad S; Tan, Kay See; Cheema, Waseem; Sanchez-Vega, Francisco; Jones, David R; Rekhtman, Natasha; Travis, William D; Hackshaw, Allan; Marafioti, Teresa; Salgado, Roberto; Le Quesne, John; Nicholson, Andrew G; McGranahan, Nicholas.
Afiliación
  • Karasaki T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Moore DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Veeriah S; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.
  • Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Toncheva A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Magno N; Department of Cellular Pathology, University College London Hospitals, London, UK.
  • Ward S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Bakir MA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Watkins TBK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Grigoriadis K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Huebner A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Frankell AM; Advanced Sequencing Facility, The Francis Crick Institute, London, UK.
  • Abbosh C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Puttick C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Zhai H; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Gimeno-Valiente F; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Saghafinia S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Kanu N; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Dietzen M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Lim EL; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Martínez-Ruiz C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Biswas D; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Campbell BB; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Lee C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Enfield KSS; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Hessey S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Litchfield K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Birkbak NJ; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Cadieux EL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Demeulemeester J; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Van Loo P; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Adusumilli PS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Tan KS; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Cheema W; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Sanchez-Vega F; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Jones DR; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Rekhtman N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Travis WD; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Hackshaw A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Marafioti T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Salgado R; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.
  • Le Quesne J; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Nicholson AG; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • McGranahan N; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Nat Med ; 29(4): 833-845, 2023 04.
Article en En | MEDLINE | ID: mdl-37045996

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido